News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Euclidean Capital LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| Euclidean Capital LLC reports a 5.1% stake in PMV PHARMACEUTICALS, INC. |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/18/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/07/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/12/2021 |
SC 13G
| Euclidean Capital LLC reports a 9.3% stake in PMV PHARMACEUTICALS, INC. |
| 09/29/2020 |
4
| Euclidean Capital LLC (Former 10% Owner) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Converted 693,769 shares
@ $0
Converted 2,601,637 shares
@ $0
Converted 751,409 shares
@ $0
Converted 132,601 shares
@ $0
Converted 693,769 preferred shares
@ $0
Converted 2,601,637 preferred shares
@ $0
Converted 751,409 preferred shares
@ $0
Converted 132,601 preferred shares
@ $0 |
|
| 09/24/2020 |
3
| Euclidean Capital LLC (10% Owner) has filed a Form 3 on PMV Pharmaceuticals, Inc. |
|
|